BIG PHARMA WATCH: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 588
Jan 7, 2022
Brand Name Drug Companies’ Business-as-Usual Approach to Price Increases… Read More
© 2024 CSRXP- All Rights Reserved
Updates
HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 400 BRAND NAME DRUGS TO RING IN 2022
Jan 3, 2022
Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers… Read More
DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I
Dec 28, 2021
Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch… Read More
DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART II
Dec 28, 2021
Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite… Read More
DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART III
Dec 28, 2021
Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual… Read More
DOSE OF REALITY: OVERSIGHT REPORT EXPOSES BIG PHARMA’S EGREGIOUS PRICING & ANTI-COMPETITIVE TACTICS — DEBUNKS INNOVATION RHETORIC
Dec 12, 2021
Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top… Read More
CSRXP: LANDMARK OVERSIGHT REPORT DEBUNKS BIG PHARMA’S FALSE RHETORIC, ADDS TO MOMENTUM TO LOWER RX PRICES
Dec 10, 2021
U.S. House Oversight & Reform Committee Report Finds Big Pharma’s… Read More
SECOND OPINION: BIG PHARMA DOUBLES DOWN ON BLAME GAME STRATEGY AMID UNPRECEDENTED MOMENTUM TO LOWER RX PRICES
Dec 3, 2021
New PhRMA Ad Campaign Aims to Dodge Accountability, Push Pharma-Backed Rebate… Read More
CSRxP: U.S. House Adds to Unprecedented Momentum to Hold Big Pharma Accountable with Passage of Rx Solutions in Build Back Better
Nov 19, 2021
Congress Must Capitalize on Historic Opportunity to Lower Drug Prices… Read More
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN BRAND NAME DRUGS COST U.S. $1.6 BILLION IN 2020
Nov 16, 2021
New Analysis Underscores How Big Pharma’s Price Increases Cost The American… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA
Nov 15, 2021
AstraZeneca’s Q3 Earnings Report Shows Pandemic Price Hikes Profitable for… Read More
CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS
Nov 12, 2021
Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical… Read More